Apogee Therapeutics, Inc.
APGEDelisted Sep 3, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001974640
Apogee Therapeutics, Inc. was delisted on Sep 3, 2026; its insiders filed their last Form 4 on Sep 3, 2026; 288 institutions reported holding it in 13F filings for Q2 2026, worth $8.93B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding Apogee Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 0 | 73 | +73 |
| Shares | 0 | 40.1M | +40.1M |
| Value | $0 | $848.7M | +$848.7M |
New holders (73)
Institutions that held Apogee Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
Sold out (0)
Institutions that held Apogee Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
None.